C2 Keep Raises $100K

C2 Keep has secured $100,000 in investment capital from investors, marking a significant milestone for the cloud-based compliance and inventory management solution provider.

The company specializes in a fully-integrated platform designed to address the complexities of Controlled Substances Act (CSA) compliance and audit preparedness for DEA registrants.

Founded by former pharmacy director Roland Achenjang after a challenging audit experience, C2 Keep aims to streamline operations and enhance security for its users.

The newly raised funds will be strategically deployed to accelerate product development and expand C2 Keep's market reach.

This investment underscores confidence in the company's mission to automate critical tasks, provide real-time insights, and simplify reporting for healthcare facilities handling controlled substances.

By enhancing its platform, C2 Keep plans to further empower users to maintain compliance and focus on patient care without the burden of manual processes.

C2 Keep's solution is currently trusted by over 2,000 DEA registrants nationwide.

Its platform helps users reduce stress, operate with greater efficiency, and ensure that patients safely receive the correct medication at the appropriate time.

The company has established itself as a go-to resource for organizations seeking to navigate the stringent requirements of CSA regulations with confidence.

Looking ahead, C2 Keep is poised for continued growth, with plans to further solidify its position as a leader in controlled substance compliance technology.

The company remains committed to innovating its platform to meet the evolving needs of DEA registrants and support their operational excellence.